Blog
Where Will Facebook Be in 5 Years?
Five years is a long time, and predicting the future path for a social media giant like Facebook (NASDAQ: FB) is fraught with uncertainties as it is with any company.
Facebook has succeeded in
Forget EVs: These 3 Stocks Are a Better Way to Play the Auto Recovery
The auto industry has had a rough go of it over the past few years. After a mini-recession resulting from the U.S.-China trade war sent auto sales down 1.4% last year, the COVID-19 pandemic put a
Is Axos Financial a Buy?
Axos Financial's (NYSE: AX) stock price has spiked in the past couple of weeks, and it has jumped over 11% in the last five trading days. That recent performance means the stock is down only about
Buy Alert: These 3 Coronavirus Stocks Are Heading Higher
The ongoing COVID-19 crisis is making its way up the list of the most deadly pandemics in human history, with more than 1 million people killed as of Oct. 7. As a second wave of infections spreads
This Billionaire Investor Was Supposed to Save Aurora Cannabis. What Happened?
It would be an understatement to say that Canadian pot producer Aurora Cannabis (NYSE: ACB) is having a tough go. The company is coming off a disappointing fourth quarter in which its sales declined
Is Alphabet Thinking of Its "Other Bets" All Wrong?
When Google officially changed its name to Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) in 2015, it was a clever play on words. The company could better be described as "Alpha" (the most powerful) and
Have You Fallen for These Three Social Security Myths?
Although Social Security is one of the most important entitlement programs in America, it's also one of the most widely misunderstood, with the majority of people lacking some fundamental knowledge
Looking for Dividends? These 3 Tech Stocks Are Great Buys
Looking for investment income? Focusing on yield alone means you'll miss out on lots of quality companies that pay a smaller dividend, but are still growing and could increase the payout in the
The Top 2 Telehealth Stocks to Buy in October
Within the span of a few months, the coronavirus pandemic has dramatically reshaped healthcare access in America. More than 76% of Americans are now considering virtual care as an option, compared
2 Healthcare Stocks That Are Perfect for Retirement
Whether you're planning for retirement or have already retired, the one thing you'll probably want from your investments is consistency. What 2020 has shown investors is just how volatile the stock
America's First Nuclear Fusion Reactor Could Go Online in 2025
In 2014, Lockheed Martin (NYSE: LMT) shocked the world with the announcement that it was building a nuclear fusion reactor and planned to have it online "in as little as ten years." Five years
Is Etsy Stock a Buy?
Propelled by a tailwind of coronavirus mask sales, Etsy (NASDAQ: ETSY) has never been more popular. Its online marketplace for handcrafted goods is attracting more buyers and artisan sellers as the
If You Invested $1,000 in Gilead Sciences' IPO, This Is How Much Money You'd Have Now
Gilead Sciences (NASDAQ: GILD) has been in the news lately, with President Trump receiving doses of Gilead's experimental antiviral drug Veklury (remdesivir) earlier this month to help treat his
Is Gilead Sciences a Buy?
I recently came across a quote from Woodrow Wilson highlighting the difference between things that follow a set of rules and those that react to changes and evolve. Wilson called the latter
Worried About Another Coronavirus Sell-Off? Buy These 3 Safe Stocks
Last week ended with the concerning news that President Donald Trump had tested positive for COVID-19. This week began with the grim news that the U.S. had hit its highest daily coronavirus
3 Reasons to Hand-Pick Stocks Instead of Buying Index Funds
Investing in the stock market is a proven way to grow wealth over time, and the sooner you get started, the better. But deciding how to invest can be challenging. If you opt for a collection of
Got $3,000? Buy These 3 Unstoppable Stocks With Multi-Bagger Potential
There's little question that the best path to wealth generation is investing in quality stocks and holding them for years and even decades. Along the way, there is the potential to find a company
3 Things to Watch for When Aphria Releases Earnings This Month
It's earnings season, and marijuana company Aphria (NASDAQ: APHA) is among the early October-filers that cannabis investors will have an eye on. The company's next earnings report will be for its
3 ETFs Perfect for Robinhood Investors
Robinhood investors have a reputation for buying high-growth stocks. Indeed, some of the most popular stocks on the platform fit that description, including Virgin Galactic Holdings, Penn National
3 "Expensive" Stocks That Are Historically Cheap
Whether you've been investing for a few months or multiple decades, it's been a buckle-up-and-hold-on sort of year. We've watched as the S&P 500 set records for the fastest bear market decline in
If You Invested $10,000 in Livongo Health's IPO, This Is How Much Money You'd Have Now
Livongo Health (NASDAQ: LVGO) stands out as one of the stocks that have benefited tremendously from the COVID-19 pandemic this year. The company's digital health platform helps individuals manage
Seniors on Medicare Who Fall Ill With COVID-19 Could Face Catastrophic Bills
We're seven months into the coronavirus pandemic, and it's clear that the problem isn't going away soon. While all Americans are vulnerable to the effects of COVID-19, seniors are, statistically
3 Top Coronavirus Stocks to Buy in October
What are the best coronavirus stocks? Ones whose COVID-19 programs aren't their only hope. The riskiest coronavirus stocks are ones that have all their chips on COVID-19 programs that aren't yet on
Where Will Moderna Be in 10 Years?
Ten years ago, Moderna (NASDAQ: MRNA) was a brand-new biotech still more than five years from advancing its first candidate into clinical testing. It was also eight years away from conducting the
What's the Outlook for Pfizer Stock?
As one of the world's largest pharmaceutical companies, Pfizer (NYSE: PFE) makes many of the most in-demand medications across the globe, netting more than $49 billion in trailing revenues in the


